Regulatory & Legal

Scientists find herpes melts the inside of our cells to replicate faster, a discovery that could revolutionize treatments for a host of viral diseases.

New preclinical data shows Quanta Therapeutics' inhibitors remain potent against cancers that have developed resistance to advanced pan-RAS treatments.

Seal Shield's strategic acquisition of Vioguard and its FDA-cleared UV-C tech marks a major step forward in the battle against healthcare-associated infections.

Online tool retailer VEVOR makes a major move into physical stores, partnering with the Houston Rockets and opening its first global flagship in the city.

A new partnership aims to solve the flexible film waste crisis, spurred by tough new laws that are forcing the packaging industry to innovate or pay.

Newly published research brings scientific rigor to the controversial kratom plant, influencing policy from the FDA to statehouses across the nation.

BioRestorative Therapies is leveraging its clinical-grade regenerative medicine to disrupt the aesthetics industry. Can science beat marketing?

A new platform in Uzbekistan merges traditional banking with crypto under a state-led framework, offering a potential blueprint for global digital finance.

With a melanoma drug on track for 2027 and a deep pipeline, Immatics' 2025 net loss is part of a larger strategy to dominate PRAME cancer therapy.

Investors eye Moody's CEO Rob Fauber's upcoming speech for insights on AI strategy, M&A forecasts, and navigating an increasingly complex global economy.

Kura Oncology's new AML drug, KOMZIFTI, sees rapid market uptake, strong financials, and an ambitious plan to reshape targeted cancer therapy.

Canada's top cannabis firm launches a fast-acting drink, leveraging brand power and nano-tech to shake up the evolving beverage market.

Select Medical's take-private deal at $16.50/share faces scrutiny as law firms question if shareholders are getting fair value from an insider-led group.

A novel oral drug for Alzheimer's avoids a key side effect of current therapies, as its 'detangler' platform shows promise for Parkinson's and other diseases.

A new report finds AI boosts elite team productivity 4x, but warns that automating mid-level tasks could create a critical cybersecurity skills gap.

The Rockefeller Foundation expands its Mission 300 Fellowship, embedding experts in 18 African nations to accelerate electrification and clean cooking access.

Backed by Nobel-winning science and French state support, Pasqal's move to go public validates the commercial promise of deep quantum technology.

Amid dire therapist shortages and post-pandemic needs, Kelly Education launches Kelly Pediatric Therapy, aiming to fix a broken system for children's care.

As Daylight Saving Time begins, Ameren urges storm readiness for a volatile season. Here’s how to protect your family from increasingly severe Midwest weather.

A new partnership between Husch Blackwell and Reunion Infrastructure promises to cut costs and complexity in the booming renewable energy tax credit market.